Feb. 10, 2021
Bamlanivimab and Etesevimab Cocktail Receives Emergency Approval for Treatment of COVID-19
FDA Grants Emergency Use Authorization for Combination Therapy
The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the investigational combination drug of bamlanivimab and etesevimab. The combination therapy is authorized to treat patients aged 12 and older who have confirmed mild to moderate COVID-19 and are at a high risk for progressing to severe COVID-19 and/or hospitalization.
Click here to read the full news release from the drug manufacturer, Eli Lilly. Other resources for healthcare providers on bamlanivimab and etesevimab are:

For any questions, feel free to reach out to Farah Jalloul, state pharmacy emergency preparedness coordinator, at Farah@MichiganPharmacists.org.
MDHHS COVID-19 Vaccination Webinar:
'Noontime Knowledge'
Have a question about COVID-19 vaccines? The Michigan Department of Health and Human Services (MDHHS) is hosting biweekly COVID-19 updates with a question-and-answer session.
Who: For Health Care Workers and COVID-19 Vaccine Providers
What: 15-20-minute discussion on select hot topics with 10-15 minutes for Q & A
When: Noon every other Thursday

Registration is not required.
Webinar Reminder:
Important Information about Moderna COVID-19 Vaccine
Moderna will host a webinar for healthcare providers to share important information about the vaccine. Registration is required. Attendees can register for one of the following webinar dates:

The webinar is not accredited for continuing education hours. 
V-Safe After Vaccination Health Checker
The Centers for Disease Control and Prevention (CDC) has implemented a system called v-safe, which is a smartphone-based tool that uses text messaging and web surveys to check in with a person after they have received COVID-19 vaccination.

V-safe will also provide second-dose reminders (if needed) and live telephone follow-up by CDC if vaccinated individuals report a medically significant event during a v-safe check-in. V-safe asks questions to monitor the safety of COVID-19 vaccines. CDC has created an information sheet that contains background on the program and instructions for enrolling.

It is important that healthcare professionals give each patient a v-safe information sheet at the time of vaccination and encourage patients to enroll. For additional information and to print the v-safe information sheet, go to the V-safe After Vaccination Health Checker by the CDC by clicking below.